
Alexander Alanine
Chief Operating Officer: Nanna Therapeutics are ambitiously delivering a range of novel therapeutics by addressing severe disorders including mitochondrial... | Cambridge, Cambridge, United Kingdom
*50 free lookup(s) per month.
No credit card required.
Alexander Alanine’s Emails al****@wa****.fr
Alexander Alanine’s Phone Numbers No phone number available.
Social Media
Alexander Alanine’s Location Cambridge, Cambridge, United Kingdom
Alexander Alanine’s Expertise Chief Operating Officer: Nanna Therapeutics are ambitiously delivering a range of novel therapeutics by addressing severe disorders including mitochondrial function as well as other areas. We also work with a limited set of pharma partners applying our unique integrated ultrahigh-throughput functional micro-droplet screening and chemistry platform, across a range of severe disorders and intelligently mining our internally generated data from 100’s of millions of biological-chemical assays per day using sophisticated machine learning to transform the speed and quality of new medicines discovery. Personal philosophy: Striving for excellence through developing people and by fostering creative thinking, collaborative problem solving with courageous, informed risk-taking supported by tolerance and learning from mistakes & failure. Professional interests,information technology and encouraging application of creative & transformative thinking skills. Skills: medicinal chemistry, innovation management, leadership, Hit2Lead, Lead optimisation, CNS, Cardiovascular/ metabolism, infectious disease expertise, parallel chemistry, chemistry technology, pharmacology, business development, external technology platform assessment, due diligence assessments of assets, contracting, work-plans. Former Director of external collaborations and technologies (chemistry), Roche. Responsibilities: - External Collaboration & Technologies Director, Pharma Research. - Workgroup co-/chair: Global compound library; therapeutic Peptides; therapeutic GPCR's, Innovation Council. - Head of Chemistry technologies and Innovation (CTI) - Head, Medicinal Chemistry-1, CNS project lead optimisation unit - Head, Lead Generation section (hit-2-lead) across therapy portfolio. - Group Leader CNS, hit-to-lead enabling medicinal chemistry.
Alexander Alanine’s Current Industry Consultant Self Employed
Alexander
Alanine’s Prior Industry
University Of Leeds
|
Eth Zurich
|
University Of Cambridge
|
Roche Pharmaceuticals
|
F Hoffmann La Roche
|
Roche
|
Bactevo
|
Nanna Therapeutics
|
Consultant Self Employed
Not the Alexander Alanine you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Consultant Self Employed
Independent biotech R&D advisor (CNS, Med-Chem., Peptides, GPCR's, CNS-Protacs, Mito. therapeutics)
Sat Oct 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Nanna Therapeutics
Chief Operating Officer (Nanna Tx) Mitochondrial Tx, neuroscience, Rare diseases, Platform Tech
Wed Aug 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Oct 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Bactevo
Chief Operating Officer (Bactevo) - Microdroplet platform: 'cellular DEL'; head of Discovery R&D
Sun Jan 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Oct 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Roche
Director, External Collaborations and Technologies, Therapeutic Modalities
Sat Jun 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Aug 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
F Hoffmann La Roche
Head, Chemistry Technologies & Innovation
Fri May 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed May 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
F Hoffmann La Roche
Section Leader, Medicinal Chemistry
Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Apr 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
F Hoffmann La Roche
Section Leader, Lead Generation
Thu Feb 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
F Hoffmann La Roche
Group leader, Lead Generation
Sat Jan 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
F Hoffmann La Roche
Group Leader in parallel chemisty Hit-2-lead, preclinical CNS
Tue Apr 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Dec 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time)
Roche Pharmaceuticals
Chemistry Team leader, preclinical CNS
Thu Sep 01 1994 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Mar 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Cambridge
Postdoctoral Fellow in the group of Professor Sir Alan Battersby FRS
Tue Oct 01 1991 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Aug 01 1994 00:00:00 GMT+0000 (Coordinated Universal Time)
Eth Zurich
Royal Society Postdoctoral Fellow, in the group of Professor Albert Eschenmoser
Thu Feb 01 1990 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Sep 01 1991 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Leeds
Generation and 1,3-dipolar cycloaddition of non-stabilised azomethine & carbonyl ylides
Wed Oct 01 1986 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Feb 01 1990 00:00:00 GMT+0000 (Coordinated Universal Time)